Medicines in development in 2009 for pancreatic cancers

[SciMedWeb]

Medicines in development in 2009 for pancreatic cancers:

● Abraxane (albumin-bound paclitaxel) Phase I/II
● Actimid (pomalidomide) Phase I/II
● aflibercept (VEGF-trap) Phase III
● AMG 479 Phase I/II
● Amplimexon (imexon) Phase II
● anti-MUC1 mAb Phase I
● ANZ-207 Phase I
● ARQ-197 Phase I/II
● ARQ-501 (beta lapachone) Phase II
● Avastin (bevacizumab) Phase III
● AVN-944 Phase II
● AZD6244 Phase II
● Camptosar (irinotecan) Phase III
● Capoxigem (apricoxib) Phase II
● CDX-1307 Phase I
● conatumumab Phase I/II
● everolimus Phase II
● FG-3019 Phase I
● GI-4000 Phase II
● glufosfamide Phase III
● Herceptin (trastuzumab) Phase II
● Hycamtin (topotecan) Phase II
● HyperAcute (pancreatric cancer vaccine) Phase II
● IMC-A12 Phase I/II
● Ixempra (ixabepilone)
● larotaxel (XRP9881) Phase III
● masitinib Phase III
● MK-0646 Phase I/II
● MKC 1 Phase II
● MORAb-009 Phase II
● naptumomab (estafenatox) Phase I
● OncoGel Phase II
● Oncophage (vitespen) Phase I/II
● OncoVEX GM-CSF Phase I
● PancAtak (gene therapy) Phase I
● PN401 Phase III
● PX-12 Phase II
● RAV-12 Phase II
● Rexin-G (tumor-targeted gene therapy) Phase I/II
● romidepsin Phase I/II
● RP-101 Phase II
● RTA-402 Phase I/II
● salirasib Phase I/II
● Sarasar (lonafarnib) Phase II
● Sutent (sunitinib) Phase III
● Thymitaq (nolatrexed) Phase II
● tigatuzumab Phase II
● TNFerade Phase III
● TPI-287 Phase II
● Triapine Phase II
● Virulizin Phase III
● volociximab Phase II
● Y-90 hPAM4 (IMMU-107) Phase I/II
● Zarnestra (tipifarnib) Phase III

InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scim...@mail.com)